INC Research

Raleigh, NC, July 26, 2010 – INC Research®, Inc., a therapeutically focused contract research organization (CRO) with a process for delivering reliable results, will feature Eli Alford, director of Global Operations Management, on a clinical trial performance improvements and metrics panel at the 10th Lean Six Sigma for Pharmaceutical, Biotech and Medical Device Excellence 2010 conference, July 26-28 at The Hilton San Diego Resort & Spa.

Alford will be joining the Metrics Champion Consortium (MCC) panel titled, “Industry-Wide Efforts to Develop and Implement Standardized Clinical Trial Performance Metrics to Drive Process Improvement” on July 28 at 4:15 p.m. This presentation will focus on how pharmaceutical, biotechnology and CROs can collaborate to define and implement a standardized set of clinical trial performance metrics with the intent to drive performance improvement of the drug development process.

Underscored by its membership in the MCC, INC Research has been refining its Trusted Process® methodology around a core set of clinical trial metrics since 2005. On the panel, Alford will present insights on creating an industry benchmarking database and how it can be used as an internal and external reporting tool. He will also discuss new approaches in measuring the quality of site assessment process, the protocol writing process and other clinical trial activities.

For more information on INC Research's Trusted Process, a proven, metrics-driven clinical trial outsourcing methodology, click here.

About INC Research® Inc.
INC Research is a therapeutically focused contract research organization with a high performance reputation for conducting global clinical development programs of the highest integrity. Pharmaceutical and biotechnology companies look to INC Research for a complete range of customized Phase I through Phase IV programs in therapeutic areas of specialty, and in innovative pediatric and women's health trials. The company's The Trusted Process® methodology and therapeutic foresight leads customers to more confident, better-informed drug and device development decisions. INC Research is headquartered in Raleigh, North Carolina. For more information please visit www.incresearch.com.